What Caught Our Attention in the Investment World? – Week of June 13-17, 2022

By Kuldip K. Ambastha On Monday, June 13, 2022, MicroStrategy Incorporated (MSTR), an American technology company, had its stock price fall by -25.2% per share. MicroStrategy offers business intelligence, mobile software, and cloud-based services, and is often in the news because of its exposure to bitcoins which secure a $205 million, 3-year loan from a …

What Caught Our Attention in the Investment World? – Week of May 23-27, 2022

By Kuldip K. Ambastha Snap Inc. (SNAP), a social media technology company with smartphone camera application Snapchat as its flagship offering, had its stock price drop by -43.1% per share on Tuesday, May 24, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 20-24, 2020; By …

What Caught Our Attention in the Investment World? – Week of May 16-20, 2022

By Kuldip K. Ambastha Ross Stores, Inc. (ROST), an American chain (“Ross Dress for Less”) of discount department stores, had its stock price drop by -22.5% per share on Friday, May 20, 2022. 1Q2022 sales were down from the same figure released for 1Q2021. Inflationary pressures have resulted in customers spending less overall, including at …

What Caught Our Attention in the Investment World? – Week of May 9-13, 2022

By Kuldip K. Ambastha The stock price of Unity Software Inc. (U), a videogame software development company, fell by -37.0% per share on Wednesday, May 11, 2022. In Unity Software’s latest quarterly conference call, company leaders disclosed impressive 1Q2022 results, but also noted disappointing 2Q2022 and 2022 full-year guidance. Wall Street was displeased with the …

What Caught Our Attention in the Investment World? – Week of May 2-6, 2022

By Kuldip K. Ambastha On Tuesday, May 3, 2022, the stock price of Chegg, Inc. (CHGG), a direct-to-student online learning platform, dropped by -30.3% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of November 1-5, 2021; By Kuldip K. Ambastha.”) In the latest quarter, the company …

What Caught Our Attention in the Investment World? – Week of April 18-22, 2022

By Kuldip K. Ambastha On Wednesday, April 20, 2022, the stock price of Netflix, Inc. (NFLX), a subscription streaming service and production company, dropped by -35.1% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of July 15-19, 2019; By Anil K. Ambastha and Kuldip K. Ambastha.”) …

What Caught Our Attention in the Investment World? – Week of November 29-December 3, 2021

By Kuldip K. Ambastha The stock of Twitter, Inc. (TWTR), a microblogging and social networking technology (tech) platform, delivered negative returns for each day of this past trading week, as the table here shows. On Monday, November 29, 2021, Jack Dorsey announced that he would step down as the Chief Executive Officer (CEO) of Twitter. …

What Caught Our Attention in the Investment World? – Week of November 8-12, 2021

By Kuldip K. Ambastha On Tuesday, November 9, 2021, shares of Roblox Corporation (RBLX), an online gaming and entertainment platform which brings people together over common interests, shot up by +42.2% for the trading day. (See What Caught Our Attention in the Investment World? – Week of March 8-12, 2021; By Kuldip K. Ambastha for …

What Caught Our Attention in the Investment World? – Week of September 27-October 1, 2021

By Kuldip K. Ambastha The stock of Dollar Tree, Inc. (DLTR), a prominent discount variety store chain operator in North America, had an impressive gain of +16.5% for the trading day of Wednesday, September 29, 2021. As dollar store chains have faced rising inflationary, raw material cost, freight shipping cost, and labor cost pressures, store …

What Caught Our Attention in the Investment World? – Week of August 30-September 3, 2021

By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …